These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33447575)

  • 1. Apparent diffusion coefficient magnetic resonance imaging (ADC-MRI) in the axillary breast cancer lymph node metastasis detection: a narrative review.
    De Cataldo C; Bruno F; Palumbo P; Di Sibio A; Arrigoni F; Clemente A; Bafile A; Gravina GL; Cappabianca S; Barile A; Splendiani A; Masciocchi C; Di Cesare E
    Gland Surg; 2020 Dec; 9(6):2225-2234. PubMed ID: 33447575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
    Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
    J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
    Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Axillary Lymph Nodes in a Sample of Iranian Women with Breast Cancer.
    Hasanzadeh F; Faeghi F; Valizadeh A; Bayani L
    Asian Pac J Cancer Prev; 2017 May; 18(5):1265-1270. PubMed ID: 28610412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
    Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
    Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat fractions from high-resolution 3D radial Dixon MRI for predicting metastatic axillary lymph nodes in breast cancer patients.
    Buus TW; Sivesgaard K; Fris TL; Christiansen PM; Jensen AB; Pedersen EM
    Eur J Radiol Open; 2020; 7():100284. PubMed ID: 33204769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-based predictive factors of axillary lymph node status in breast cancer.
    Atallah D; Moubarak M; Arab W; El Kassis N; Chahine G; Salem C
    Breast J; 2020 Nov; 26(11):2177-2182. PubMed ID: 33073463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
    Fornasa F; Nesoti MV; Bovo C; Bonavina MG
    J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
    Choi EJ; Youk JH; Choi H; Song JS
    J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
    Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
    J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
    Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
    Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
    Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Diffusion-Weighted Imaging and Related Apparent Diffusion Coefficient be a Prognostic Value in Women With Breast Cancer?
    Rabasco P; Caivano R; Simeon V; Dinardo G; Lotumolo A; Gioioso M; Villonio A; Iannelli G; D'Antuono F; Zandolino A; Macarini L; Guglielmi G; Cammarota A
    Cancer Invest; 2017 Feb; 35(2):92-99. PubMed ID: 28107084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
    De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
    J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
    Kato F; Kudo K; Yamashita H; Baba M; Shimizu A; Oyama-Manabe N; Kinoshita R; Li R; Shirato H
    Breast Cancer; 2019 Sep; 26(5):628-636. PubMed ID: 30937834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficient.
    Rautiainen S; Könönen M; Sironen R; Masarwah A; Sudah M; Hakumäki J; Vanninen R; Sutela A
    PLoS One; 2015; 10(3):e0122516. PubMed ID: 25823016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.